Skip to main navigation Skip to search Skip to main content

Twenty-four–Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes – Protocol 3 with High Dose (READ-3) Study

  • Yasir J. Sepah
  • , Mohammad Ali Sadiq
  • , David Boyer
  • , David Callanan
  • , Ron Gallemore
  • , Michael Bennett
  • , Dennis Marcus
  • , Lawrence Halperin
  • , Muhammad Hassan
  • , Peter A. Campochiaro
  • , Quan Dong Nguyen
  • , Diana V. Do
  • , Eugene Lit
  • , Erik Kruger
  • , John Pollack
  • , Kang Zhang
  • , Andrew Symons
  • , Prema Abraham
  • , Brian P. Conway
  • , David J. Wilson
    • Mostafa Hanout, Aniruddha Agarwal, Rubbia Afridi, Lisa Greer

Research output: Contribution to journal › Article › peer-review

19   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Twenty-four–Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes – Protocol 3 with High Dose (READ-3) Study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science